CTSI Update: Upcoming Deadlines

We are delighted to announce that the BU CTSI will support two post-Doctoral fellows as part of the CTSI training program in regenerative medicine. This program is committed to increasing the diversity of the research workforce and strongly encourages applications from underrepresented, racial, and ethnic groups (UREGs). Read More.

An interactive training program that uses case studies developed and vetted with other Clinical & Translational Science Institutes around the country. This is a great opportunity to interact with and learn from colleagues in other disciplines. A certificate will be supplied to include in your training grant applications. Read More
Funding Opportunities

Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center (U24 Clinical Trial Required)

Health Resources and Services Administration (HRSA) Administration for Children and Families (ACF)

Immune Cell Engineering For Targeted Therapy And Disease Monitoring in Type 1 Diabetes (R01 Clinical Trial Not Allowed)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Notice of Special Interest (NOSI): Secondary Analysis of Existing Datasets for Advancing Immune-mediated and Infectious Disease Research

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Mental Health (NIMH)

Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies

National Institute of General Medical Sciences (NIGMS)

Notice of Special Interest (NOSI): Translation of Quantitative Imaging tools and Methods for the Academic Industrial Partnership

National Cancer Institute (NCI)

Notice of Special Interest (NOSI): National Research Service Award (NRSA) F32 Postdoctoral Fellowship Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities

National Eye Institute (NEI)

This FOA invites applications that will support a Dietary Assessment Center that
will conduct an innovative dietary assessment on all participants and develop innovative approaches to address dietary assessment challenges.
News Highlights
Is One Vaccine Dose Enough After COVID-19 Infection?

For the millions of Americans now eligible to receive the Pfizer or Moderna COVID-19 vaccines, it’s recommended that everyone get two shots. The first dose of these mRNA vaccines trains the immune system to recognize and attack the spike protein on the surface of SARS-CoV-2, the virus that causes COVID-19. Read More
NIH Funds Study to Evaluate Remdesivir for COVID-19 in Pregnancy

Pregnant women with COVID-19 are at high risk for hospitalization, for intensive care admission, and for needing ventilator support,” There is an urgent need to identify effective treatments for this population and to determine whether drugs prescribed for other adults are appropriate for use in pregnancy.” Read More
South Africa Study Shows Power of Genomic Surveillance Amid COVID-19 Pandemic

Considerable research is underway around the world to monitor the spread of new variants of SARS-CoV-2, the coronavirus that causes COVID-19. That includes variant B.1.351 (also known as 501Y.V2), which emerged in South Africa towards the end of 2020. Read More
Upcoming Event

Specifying Joint and Cartilage Lineages in the Pluripotent Stem Cell Model”
Mar. 03, 2021, 12 - 1 p.m.

April Craft, PhD
Assistant Professor of Orthopedic Surgery
Boston Children’s Hospital
Principal Faculty, Harvard Stem Cell Institute
Meeting ID: 992 8266 0633
Passcode: 336708
Boston University Logo
Accelerating Discoveries Towards Better Health 
bu.edu/ctsi | ncats.nih.gov